Qube Research & Technologies (QRT)
VNDA icon

Qube Research & Technologies (QRT)’s Vanda Pharmaceuticals VNDA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.46M Buy
+729,212
New +$4.76M ﹤0.01% 1690
2026
Q1 		– Sell
-20,656
Closed -$182K – 4181
2025
Q4 		$182K Sell
20,656
-158,596
-88% -$873K ﹤0.01% 3077
2025
Q3 		$894K Buy
+179,252
New +$830K ﹤0.01% 2567
2025
Q2 		– Sell
-21,362
Closed -$98.1K – 4015
2025
Q1 		$98.1K Sell
21,362
-6,119
-22% -$28.5K ﹤0.01% 3008
2024
Q4 		$132K Buy
+27,481
New +$132K ﹤0.01% 2933
2024
Q2 		– Sell
-370,246
Closed -$1.52M – 4786
2024
Q1 		$1.52M Sell
370,246
-38,967
-10% -$156K ﹤0.01% 1905
2023
Q4 		$1.73M Buy
409,213
+153,488
+60% +$619K ﹤0.01% 1604
2023
Q3 		$1.1M Buy
+255,725
New +$1.42M ﹤0.01% 1668
2023
Q1 		– Sell
-57,042
Closed -$422K – 3059
2022
Q4 		$422K Buy
+57,042
New +$556K ﹤0.01% 1538
2022
Q3 		– Sell
-57,842
Closed -$630K – 3068
2022
Q2 		$630K Sell
57,842
-30,234
-34% -$313K ﹤0.01% 1309
2022
Q1 		$996K Buy
88,076
+7,297
+9% +$95.9K 0.01% 1173
2021
Q4 		$1.27M Buy
+80,779
New +$1.41M 0.01% 1054
2021
Q2 		– Sell
-64,980
Closed -$976K – 2841
2021
Q1 		$976K Buy
64,980
+48,656
+298% +$788K 0.02% 854
2020
Q4 		$214K Buy
16,324
+670
+4% +$8.06K ﹤0.01% 1507
2020
Q3 		$151K Buy
+15,654
New +$167K ﹤0.01% 1448
2020
Q1 		– Sell
-12,036
Closed -$198K – 1705
2019
Q4 		$198K Buy
+12,036
New +$182K 0.01% 1396

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Qube Research & Technologies (QRT)'s VNDA Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Vanda Pharmaceuticals (VNDA) in Q2 2026: 729,212 shares worth $4.46M. The stake represents ﹤0.01% of the portfolio and ranks #1690 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in VNDA as recently as Q4 2025.

Qube Research & Technologies (QRT) first reported a position in VNDA in Q4 2019 and has held it in 16 quarters since. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Qube Research & Technologies (QRT) held 729,212 shares of Vanda Pharmaceuticals worth $4.46M as of Q2 2026.
  • Vanda Pharmaceuticals was a new Qube Research & Technologies (QRT) position in Q2 2026.
  • Vanda Pharmaceuticals made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1690 holding.
  • Qube Research & Technologies (QRT) first reported a position in Vanda Pharmaceuticals in Q4 2019 and has held it in 16 quarters since.
  • 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.